Sfoglia per AUTORE
TORRI V
Collezione ASL Biella

  

Items : 12

Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund. in Tumori / Tumori. 2024 Jun;110(3):168-173. doi: 10.1177/03008916241229287. Epub 2024 Feb 19.

2024
ASL Biella
AOU Alessandria
ASL Cuneo 2
ASL Città di Torino

Ceresoli GL; Garassino MC; Torri V; Grosso F; Petraglia S; Pasello G; Cuppone F; Verderame F; De Simone I; Gauna R; Alabiso I; Biello F; Dellepiane C; Proto C; Lo Russo G; Occhipinti M; De Angelis AM; Mazzeo L; Crivellari S; Delfanti S; Cerbone L;

Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial. in ESMO open / ESMO Open. 2020 Sep;5(5):e000911. doi: 10.1136/esmoopen-2020-000911.

2020
ASL Biella

Siena S; Bardelli A; Trusolino L; Marsoni S; Cappello G; Regge D; Sapino A; Vanzulli A; Torri V; Bonoldi E; Grassi E; Amatu A; Bencardino K; Valtorta E; Ardizzoni A; Ciardiello F; Zagonel V; Bergamo F; Leone F; Martino C; Fenocchio E; Ghezzi S; Tosi F; Lonardi S; Sartore-Bianchi A;

Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment. in Haematologica / Haematologica. 2020 Nov 1;105(11):2592-2597. doi: 10.3324/haematol.2019.237990.

2020
ASL Biella

Zucca E; Johnson PW; Cavalli F; Lopez Guillermo A; Raderer M; Gaidano G; Margiotta Casaluci G; Kiesewetter B; Torri V; Cascione L; Conconi A; Thieblemont C;

Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088). in Trials / Trials. 2020 Jul 25;21(1):678. doi: 10.1186/s13063-020-04568-9.

2020
AOU Alessandria
ASL Biella

Torri V; Orecchia S; Fusco V; Traverso E; Solaini L; Ercolani G; Cavaliere D; Buccianti P; Balestri R; Ceccarelli C; Coratti A; Menegatti B; Perna F; Contardo T; Mammano E; Morpurgo E; Pulighe F; De Nisco C; Pernazza G; Ruffo G; Alongi F; Bertocchi E; Gori S; Perinotti R; Rosati R; Delpini R; Boni L; Elmore U; Baldari L; et alii...

Correction to: Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2020 Feb 17;20(1):128. doi: 10.1186/s12885-020-6632-y.

2020
ASL Biella
AOU Alessandria
AOU Novara

Franzone P; Numico G; Priora F; Rossi M; Fusco V; Traverso E; Torri V; Cavaliere D; Solaini L; Ercolani G; Ceccarelli C; Balestri R; Buccianti P; Baroffio P; Gentilli S; Menegatti B; Coratti A; Perna F; Rosati R; Delpini R; Elmore U; Mammano E; Contardo T; Morpurgo E; Perinotti R; De Nisco C; Pulighe F; Pernazza G; Boni L; et alii...

Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer. in Clinical colorectal cancer / Clin Colorectal Cancer. 2020 Dec;19(4):256-262.e2. doi: 10.1016/j.clcc.2020.06.009. Epub 2020 Jun 27

2020
ASL Biella

Marsoni S; Trusolino L; Zagonel V; Bardelli A; Regge D; Ciardiello F; Cassingena A; Cappello G; Bonoldi E; Vanzulli A; Marrapese G; Valtorta E; Mauri G; Torri V; Siravegna G; Troiani T; Martinelli E; Bonazzina E; Fenocchio E; Bergamo F; Bencardino K; Amatu A; Leone F; Ghezzi S; Martino C; Siena S; Tosi F; Sartore-Bianchi A; Lonardi S; et alii...

Standard (8 weeks) vs long (12 weeks) Timing to Minimally-Invasive Surgery after NeoAdjuvant Chemoradiotherapy for Rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR) in European Journal of Surgical Oncology

2020
ASL Biella

Monsellato I; Ruffo G; Alongi F; Bertocchi E; Boni L; Cassinotti E; Pernazza G; Pulighe F; Perinotti R; Morpurgo E; Mammano E; Elmore U; Gentilli S; Baroffio P; Torri V; Traverso E; Priora F; Numico G; Franzone P;

Standard (8?weeks) vs long (12?weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR). in BMC cancer / BMC Cancer. 2019 Dec 16;19(1):1215. doi: 10.1186/s12885-019-6271-3.

2019
ASL Biella
AOU Alessandria
AOU Novara

Orecchia S; Numico G; Franzone P; Priora F; Rossi M; Fusco V; Traverso E; Ercolani G; Cavaliere D; Solaini L; Torri V; Ceccarelli C; Buccianti P; Balestri R; Menegatti B; Gentilli S; Baroffio P; Perna F; Coratti A; Delpini R; Rosati R; Elmore U; Mammano E; Pulighe F; De Nisco C; Perinotti R; Morpurgo E; Boni L; Contardo T; et alii...

Early progression of disease (POD24) as survival predictor in MALT lymphoma in Journal of Clinical Oncology

2019
ASL Biella

Conconi A; Thieblemont C; Cascione L; Torri V; Kiesewetter B; Margiotta-Casaluci G; Gaidano G; Raderer M; Cavalli F; Lopez-Guillermo A; Johnson PWM; Zucca E;

A MALT lymphoma prognostic index. in Blood / Blood. 2017 Sep 21;130(12):1409-1417. doi: 10.1182/blood-2017-03-771915. Epub 2017 Jul 18.

2017
ASL Biella

Zucca E; Torri V; Cavalli F; Johnson PW; Lopez Guillermo A; Coiffier B; Laszlo D; Martelli M; Gaidano G; Kiesewetter B; Raderer M; Conconi A; Cascione L; Thieblemont C;

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Jun 10;35(17):1905-1912. doi: 10.1200/JCO.2016.70.6994. Epub 2017 Mar 29.

2017
ASL Biella
AOU Città della Salute di Torino

Thieblemont C; Johnson P; Cavalli F; Mazzucchelli L; Campo E; Jack A; Moreau A; Ponzoni M; Bellei M; Stelitano C; Haioun C; Bosly A; Zachée P; Ferreri AJM; Hohaus S; Torri V; Tilly H; Morschhauser F; Devizzi L; Pinotti G; Guillermo AL; Sebban C; Salles G; Pettengell R; Martelli M; Vitolo U; Tucci A; Martinelli G; Bouabdallah R; et alii...

A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 Feb;27(2):274-80. doi: 10.1093/annonc/mdv541. Epub 2015 Nov 16.

2016
ASL Biella

Fossati R; Mosconi P; Torri V; Negri E; Zaniboni A; Monteforte M; Labianca R; Apolone G; Johnson F; Pignata S; Pavia G; Solina G; Pancera G; Sozzi P; Pinna N; Duro M; Martignoni G; Oliverio G; Daniele B; Gaion F; Corradini G; Luchena G; Andreoni B; Barni S; Rosati G; Ambrosini G;